Home Cart 0 Sign in  

[ CAS No. 40876-98-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 40876-98-0
Chemical Structure| 40876-98-0
Structure of 40876-98-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 40876-98-0 ]

Related Doc. of [ 40876-98-0 ]

Alternatived Products of [ 40876-98-0 ]

Product Details of [ 40876-98-0 ]

CAS No. :40876-98-0 MDL No. :MFCD00035571
Formula : C8H11NaO5 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 210.16 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 40876-98-0 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.5
Num. rotatable bonds : 6
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.3
TPSA : 75.66 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.62 cm/s

Lipophilicity

Log Po/w (iLOGP) : -11.8
Log Po/w (XLOGP3) : 1.35
Log Po/w (WLOGP) : 0.43
Log Po/w (MLOGP) : 0.01
Log Po/w (SILICOS-IT) : 0.32
Consensus Log Po/w : -1.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.6
Solubility : 5.31 mg/ml ; 0.0253 mol/l
Class : Very soluble
Log S (Ali) : -2.54
Solubility : 0.605 mg/ml ; 0.00288 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.36
Solubility : 91.7 mg/ml ; 0.437 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.58

Safety of [ 40876-98-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 40876-98-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 40876-98-0 ]
  • Downstream synthetic route of [ 40876-98-0 ]

[ 40876-98-0 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 40876-98-0 ]
  • [ 37687-26-6 ]
Reference: [1] Patent: US9273058, 2016, B2,
  • 2
  • [ 3473-63-0 ]
  • [ 40876-98-0 ]
  • [ 6299-87-2 ]
YieldReaction ConditionsOperation in experiment
25%
Stage #1: With sodium hydroxide In water at 20℃; for 16 h;
Stage #2: With hydrogenchloride In water at 0℃; for 1 h;
In a 1 L round bottom flask, 55 g of sodium ethyloxalacetate (1.05 eq, 0.26 mol) and 26 g of formamidine acetate (1 eq, 0.25 mol) were added to a solution of sodium hydroxide (10 g) in 500 mL of water. The reaction mixture was stirred at room temperature for 16 hours.[00262] Concentrated HCl was added carefully to the mixture until pH = 1, a fine solid precipitated and the reaction mixture was stirred at 0°C for 1 hour. The solid was filtered then washed with water and ether. The white solid was then left in a vacuum oven heated at4O0C for 20 hours. Trituration in methanol gave the title compound in 25percent yield. 1H NMR(dβ-DMSO): 12.88 (IH, OH), 8.24 (s, IH), 6.83 (s, IH).
15% With sodium hydroxide In water at 20℃; for 12 h; To a solution of formamidine acetate (10 g, 96 mmol) in 200 mL of water was added diethyl oxalacetate sodium salt (21 g, 100 mmol) and sodium hydroxide (3.8 g, 96 mmol). The reaction mixture was stirred overnight at room temperature, before 6 N HCl was added carefully to adjust PH = 1. The mixture was allowed to stand overnight at 0 °C, and the resultant precipitate was filtered and dried in vacuum to give the desired product (2 g, 15percent) as a red solid. 1H NMR (400 MHz, DMSO-d6) δ 12.90 (s, 1H), 8.25 (s, 1H), 6.83 (s, 1H).
Reference: [1] Patent: WO2010/20432, 2010, A2, . Location in patent: Page/Page column 91
[2] European Journal of Medicinal Chemistry, 2018, vol. 149, p. 30 - 44
[3] Patent: US2011/21500, 2011, A1, . Location in patent: Page/Page column 39
[4] Patent: US2011/59954, 2011, A1, . Location in patent: Page/Page column 71
[5] Patent: US2011/172218, 2011, A1, . Location in patent: Page/Page column 28
[6] Patent: US2011/195954, 2011, A1, . Location in patent: Page/Page column 79
  • 3
  • [ 6313-33-3 ]
  • [ 40876-98-0 ]
  • [ 6299-87-2 ]
YieldReaction ConditionsOperation in experiment
37%
Stage #1: at 20℃; for 0.666667 h;
Stage #2: With sodium hydroxide In water at 0℃;
Preparation of -hydroxypyrimidine-^carboxylic acid:; To a suspension of 2.52 g (12.0 mmol) of diethyloxaloacetate sodium salt in 8 mL of water was added 1.9 mL of 6.25 M NaOH(α? ), dropwise over 1 min. The mixture was stirred at ambient temperature for 40 min to give an orange solution. Next, 2.1 g (26 mmol) of formamidine hydrochloride in 2 mL of water was added. The reaction was cooled with an ice bath, and with the aid of a pH meter, the pH was maintained between 1 1 and 1 1.5, by the addition of 6.25 M NaOH as the reaction progressed over 40 min. The pH was then adjusted to 1 by the addition of 12 M HCl, giving a white precipitate. This was filtered, washed with 0.1 M HCl (2 x 5 mL), then dried on the filter to give 618 mg (37percent) of a light tan solid.
Reference: [1] Patent: WO2009/61453, 2009, A1, . Location in patent: Page/Page column 115
  • 4
  • [ 60-34-4 ]
  • [ 40876-98-0 ]
  • [ 51986-17-5 ]
YieldReaction ConditionsOperation in experiment
71.8% With acetic acid In ethanol at 20℃; for 7.5 h; Heating / reflux (Reference Example 3)
Synthesis of 3-ethoxycarhonyl-5-hydroxy-1-methylpyrazole
50.0 g (0.24 mole) of diethyl oxaloacetate sodium salt was suspended in 500 ml of ethanol.
Thereto was added 25 ml of acetic acid.
Thereto was dropwise added, at room temperature in 0.5 hour with stirring, 15 g (0.33 mole) of 97percent methylhydrazine.
After the dropwise addition, the mixture was stirred at room temperature for 2 hours and successively at the refluxing temperature for 5 hours.
After cooling, ethanol was distilled off under reduced pressure.
To the residue were added 200 ml of ethyl acetate and 100 ml of water.
After phase separation, the aqueous layer was subjected to re-extraction with 50 ml of ethyl acetate.
The two ethyl acetate layers were combined and washed with 50 ml of water and 50 ml of a saturated aqueous sodium chloride 50 ml of a saturated aqueous sodium chloride solution in this order.
The resulting ethyl acetate layer was dried over anhydrous sodium sulfate and subjected to vacuum distillation to remove the solvent.
To the resulting crystals was added 100 ml of water.
53% With sulfuric acid In methylated spirits 74OP at 25 - 60℃; for 5.25 h; Heating / reflux Ester formationConcentrated sulphuric acid (13.5g:013 mol) was added dropwise over 5 min to stirred methylated spirits 74OP (100ml) and then cooled to <30C. Methyl hydrazine (11.51g; 0.25mol) was added dropwise over 10min at <60C and the mixture then cooled to 25C, followed by the addition diethyl oxalacetate sodium salt (60.84g; 0.275mol). After stirring for 2 hours the temperature was raised to reflux and maintained for 3 hours, cooled and then filtered. The filtrates evaporated and the resulting residue stirred with water. The product was filtered and washed with water before being recrystallised from water to give an off white solid (22.84g:53percent: mass spectrum (M-H) -ve 169)
Reference: [1] Patent: EP1990336, 2008, A1, . Location in patent: Page/Page column 12
[2] Patent: WO2008/47071, 2008, A1, . Location in patent: Page/Page column 20
[3] Patent: EP1988081, 2008, A1, . Location in patent: Page/Page column 40
  • 5
  • [ 7339-53-9 ]
  • [ 40876-98-0 ]
  • [ 51986-17-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 4, p. 1228 - 1234
  • 6
  • [ 141-78-6 ]
  • [ 95-92-1 ]
  • [ 40876-98-0 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1888, vol. 246, p. 324
[2] Gazzetta Chimica Italiana, 1887, vol. 17, p. 520[3] Gazzetta Chimica Italiana, 1890, vol. 20, p. 169,170
[4] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 1, p. 218,597
[5] Justus Liebigs Annalen der Chemie, 1888, vol. 246, p. 324
[6] Gazzetta Chimica Italiana, 1887, vol. 17, p. 520[7] Gazzetta Chimica Italiana, 1890, vol. 20, p. 169,170
[8] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 1, p. 218,597
[9] Fortschr. Teerfarbenfabr. Verw. Industriezweige, 1, 218; 1, 597,
[10] Fortschr. Teerfarbenfabr. Verw. Industriezweige, 1, 218; 1, 597,
  • 7
  • [ 40876-98-0 ]
  • [ 691-84-9 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1991, # 3, p. 601 - 605
  • 8
  • [ 40876-98-0 ]
  • [ 85230-37-1 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: With acetic acid In toluene at 20℃; for 0.5 h;
Stage #2: With hydrazine hydrochloride In toluene at 100℃;
Acetic acid (150 mL) was added drop-wise to a solution of sodium 1 ,4-diethoxy- (0282) 1 ,4-dioxobut-2-en-2-olate (30.0 g, 0.143 mol) in toluene (150 mL), and the mixture was stirred at room temperature for 30 minutes, whereupon hydrazine monohydrochloride (85percent, 17 g, 0.29 mol) was added. The reaction mixture was stirred for an additional 30 minutes at room temperature and subsequently heated at 100 °C overnight. It was then concentrated in vacuo and extracted with ethyl acetate (500 mL); the organic layer was washed sequentially with saturated aqueous sodium bicarbonate solution (200 mL) and saturated aqueous sodium chloride solution (200 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure to provide the product as a yellow solid. Yield: 17 g, 0.1 1 mol, 77percent. 1H NMR (400 MHz, DMSO-cf6) δ 12.75 (br s, 1 H), 5.91 (br s, 1 H), 4.24 (q, J=7 Hz, 2H), 1 .27 (t, J=7 Hz, 3H).
Reference: [1] Patent: WO2017/145013, 2017, A1, . Location in patent: Page/Page column 54
[2] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 4, p. 1228 - 1234
  • 9
  • [ 40876-98-0 ]
  • [ 153597-59-2 ]
Reference: [1] Patent: WO2017/145013, 2017, A1,
  • 10
  • [ 57297-29-7 ]
  • [ 40876-98-0 ]
  • [ 858956-25-9 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: for 0.333333 h;
Stage #2: at 70℃;
Stage #3: With hydrogenchloride In water at 20℃;
A solution of sodium hydroxide (2.85 g, 71.3 mmol) in water (3 ml) was added to a stirred solution of diethyl oxaloacetate sodium salt (8.7 g, 50 mmol) in water (50 ml) and the mixture stirred for 20 minutes. Cyclopropylcarboxamidine hydrochloride salt (5.0 g, 40 mmol) was added to the solution and the mixture was heated at 70 0C overnight, then cooled to ambient temperature and acidified to pH1 by the cautious addition of concentrated hydrochloric acid. The precipitate was isolated by filtration and dried to yield 2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic acid (4.7 g, 63percent). Characterising data for the compound are as follows: 1H nmr (400MHz, d6-DMSO) δH 13.30 (1H, br s), 12.97 (1H, br s), 6.59 (1H, s), 1.94 (1H, quintet), 1.04 (4H, m) ppm.
63%
Stage #1: With sodium hydroxide In water for 0.333333 h;
Stage #2: at 70℃;
Stage #3: With hydrogenchloride In water at 20℃;
A solution of sodium hydroxide (2.85 g, 71.3 mmol) in water (3 ml) was added to a stirred solution of diethyl oxaloacetate sodium salt (8.7 g, 50 mmol) in water (50 ml) and the mixture stirred for 20 minutes. Cyclopropylcarboxamidine hydrochloride salt (5.0 g, 40 mmol) was added to the solution and the mixture was heated at 70 0C overnight, then cooled to ambient temperature and acidified to pH1 by the cautious addition of concentrated hydrochloric acid. The precipitate was isolated by filtration and dried to yield 2-cyclopropyl-4-hydroxypyrimidine-6-carboxylic acid (4.7 g, 63percent). 1H nmr (400MHz, d6-DMSO) δH 13.30 (1 H, br s), 12.97 (1 H, br s), 6.59 (1 H, s), 1.94 (1 H, quintet), 1.04 (4H, m) ppm.
Reference: [1] Patent: WO2009/81112, 2009, A2, . Location in patent: Page/Page column 114
[2] Patent: WO2010/92339, 2010, A1, . Location in patent: Page/Page column 83-84
Same Skeleton Products
Historical Records

Similar Product of
[ 40876-98-0 ]

Chemical Structure| 108-56-5

A357642[ 108-56-5 ]

Diethyl 2-oxobutanedioate

Reason: Free-salt

Related Functional Groups of
[ 40876-98-0 ]

Alkenes

Chemical Structure| 2459-05-4

[ 2459-05-4 ]

(E)-4-Ethoxy-4-oxobut-2-enoic acid

Similarity: 0.69

Chemical Structure| 2396-84-1

[ 2396-84-1 ]

(2E,4E)-Ethyl hexa-2,4-dienoate

Similarity: 0.65

Chemical Structure| 5941-55-9

[ 5941-55-9 ]

Ethyl (E)-3-Ethoxyacrylate

Similarity: 0.63

Chemical Structure| 105-76-0

[ 105-76-0 ]

Dibutyl maleate

Similarity: 0.63

Chemical Structure| 638-10-8

[ 638-10-8 ]

Ethyl 3-methylbut-2-enoate

Similarity: 0.63

Aliphatic Chain Hydrocarbons

Chemical Structure| 2459-05-4

[ 2459-05-4 ]

(E)-4-Ethoxy-4-oxobut-2-enoic acid

Similarity: 0.69

Chemical Structure| 5941-55-9

[ 5941-55-9 ]

Ethyl (E)-3-Ethoxyacrylate

Similarity: 0.63

Chemical Structure| 105-76-0

[ 105-76-0 ]

Dibutyl maleate

Similarity: 0.63

Chemical Structure| 638-10-8

[ 638-10-8 ]

Ethyl 3-methylbut-2-enoate

Similarity: 0.63

Chemical Structure| 2756-87-8

[ 2756-87-8 ]

(E)-4-methoxy-4-oxobut-2-enoic acid

Similarity: 0.63

Esters

Chemical Structure| 614-99-3

[ 614-99-3 ]

Ethyl furan-2-carboxylate

Similarity: 0.73

Chemical Structure| 53662-83-2

[ 53662-83-2 ]

Diethyl furan-2,5-dicarboxylate

Similarity: 0.73

Chemical Structure| 6270-57-1

[ 6270-57-1 ]

Diethyl 3,4-dihydroxyfuran-2,5-dicarboxylate

Similarity: 0.71

Chemical Structure| 2527-96-0

[ 2527-96-0 ]

Methyl 5-methylfuran-2-carboxylate

Similarity: 0.70

Chemical Structure| 4282-32-0

[ 4282-32-0 ]

Dimethyl furan-2,5-dicarboxylate

Similarity: 0.70